Generics - Mylan Laboratories, Generics

Filter

Popular Filters

1 to 25 of 94 results

US Supreme Court denies Teva's request for injunction relating to Mylan’s generic Copaxone

21-04-2014

The US Supreme Court Chief Justice Roberts has denied Israeli generics giant Teva Pharmaceutical Industries’…

CopaxoneGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaPatentsTeva Pharmaceutical IndustriesUSA

Mylan settles over generic Generess tablets and launches insomnia drug

Mylan settles over generic Generess tablets and launches insomnia drug

16-04-2014

US generics major Mylan (Nasdaq: MYL) and its partner Famy Care have entered into a settlement and license…

ActavisFamy CareGeneress FeGenericsHealth Medical PharmaLegalLunestaMylanMylan LaboratoriesPharmaceutical sciencesPharmacologyUSAWomen's Health

Prosonix and Mylan in deal for Flixotide and Flovent generics

15-04-2014

Prosonix, a UK-based company which is developing a portfolio of inhaled “Respiratory Medicines by Design,”…

FloventGenericsGlaxoSmithKlineGlobalLicensingMylan LaboratoriesProsonixRespiratory and Pulmonary

US Judge enforces settlement deal between Mylan and Endo over generic Frova

US Judge enforces settlement deal between Mylan and Endo over generic Frova

11-04-2014

US generic major Mylan today confirmed that a federal district court has granted its request to enforce…

Endo Health SolutionsEndo PharmaceuticalsFrovaGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaPatentsUSA

Sweden’s Meda rejects Mylan’s takeover overture

Sweden’s Meda rejects Mylan’s takeover overture

06-04-2014

After a day of rumor and speculation about a takeover approach from US generic firm Mylan, Swedish drugmaker…

GenericsMedaMergers & AcquisitionsMylan Laboratories

Mylan prevails in breach of contract case against GlaxoSmithKline

Mylan prevails in breach of contract case against GlaxoSmithKline

27-03-2014

US generics major Mylan reveals that, after a trial in the US District Court for the District of New…

GenericsGlaxoSmithKlineLegalMylan LaboratoriesNeurologicalparoxetinePaxil-CR

US District Court upholds Mylan's US patents on Perforomist Inhalation Solution

25-03-2014

US generics major Mylan says the US District Court for the Northern District of West Virginia issued…

GenericsLegalMylan LaboratoriesNorth AmericaPatentsPerforomistRespiratory and PulmonaryTeva Pharmaceutical IndustriesUSA

Mylan pushes further into India, introducing critical care segment

Mylan pushes further into India, introducing critical care segment

12-03-2014

US generics major Mylan says its Indian subsidiary has launched a Critical Care segment in India. The…

AmbisomeAntibiotics and Infectious diseasesAsia-PacificGenericsIndiaMarkets & MarketingMylan Laboratories

Mylan 4th-qtr 2013 adjusted diluted EPS increases 20%, beating expectations

27-02-2014

US generics major Mylan reported financial results for the fourth-quarter and full year 2013, showing…

FinancialGenericsMylan Laboratories

Mylan debuts Hertraz, first Herceptin biosimilar, in India

Mylan debuts Hertraz, first Herceptin biosimilar, in India

03-02-2014

US generics major Mylan has launched the world's first trastuzumab biosimilar in India. The product,…

Asia-PacificBioconBiosimilarsGenericsHerceptinHertrazIndiaMarkets & MarketingMylan LaboratoriesOncologyRoche

Mylan hires Rakesh Bamzai as president, India commercial and emerging markets

Mylan hires Rakesh Bamzai as president, India commercial and emerging markets

04-01-2014

US drugmaker Mylan says that Rakesh Bamzai has joined the company and has been appointed president, India…

BoardroomGenericsManagementMylan Laboratories

Patent settlements for Pfizer/Teva and Mylan/Eisai

Patent settlements for Pfizer/Teva and Mylan/Eisai

18-12-2013

US pharma behemoth Pfizer says it has settled its long-standing litigation against a US subsidiary of…

Banner PharmacapsEisaiGenericsLegalMen's HealthMylan LaboratoriesNorth AmericaOncologyPatentsPfizerTargretinTeva Pharmaceutical IndustriesValeant PharmaceuticalsViagra

Mylan-Biocon Herceptin biosimilar gets first Indian approval

Mylan-Biocon Herceptin biosimilar gets first Indian approval

26-11-2013

US generic major Mylan says that its partner, India-based biotechnology firm Biocon has received approval…

Asia-PacificBioconBiosimilarsGenericsHerceptinHertrazMylan LaboratoriesOncologyRegulationRoche

Mylan launches first generic Focalin XR capsules

Mylan launches first generic Focalin XR capsules

18-11-2013

US generics major Mylan has launched dexmethylphenidate hydrochloride extended-release (ER) capsules,…

Focalin XRGenericsMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaNovartis

Mylan launches first generic of Pfizer antifungal

Mylan launches first generic of Pfizer antifungal

30-09-2013

Mylan says it has launched voriconazole for oral suspension, which is the first generic version of Pfizer's…

Antibiotics and Infectious diseasesGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaPfizerVfend

US FTC calls for divestments for Mylan acquisition of Agila Specialties to proceed

US FTC calls for divestments for Mylan acquisition of Agila Specialties to proceed

27-09-2013

The USA’s Federal Trade Commission will require Mylan and Agila Specialties to divest 11 generic injectable…

Agila SpecialitesGenericsMergers & AcquisitionsMylan LaboratoriesNorth AmericaStrides Arcolab

Teva gains favorable court ruling in Azilect patent case

Teva gains favorable court ruling in Azilect patent case

24-09-2013

Israel-based Teva Pharmaceutical Industries has gained a favorable ruling in its patent infringement…

AzilectGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaTeva Pharmaceutical Industries

Mylan cleared to sell generic Wellbutrin XL in USA

26-08-2013

There was good news last week for US specialty and generics company Mylan (Nasdaq: MYL), when the US…

GenericsGlaxoSmithKlineMylan LaboratoriesNeurologicalNorth AmericaRegulationWellbutrin XL

Mylan's deal to acquire Strides Arcolab's unit looks set to proceed

22-08-2013

US generics and specialty drugmaker Mylan (NYSE: MYL) $1.6-billion foreign direct investment proposal…

Agila SpecialitesAsia-PacificGenericsMergers & AcquisitionsMylan LaboratoriesRegulationStrides Arcolab

Mylan's 2nd-qtr misses consensus on sales but beats on EPS

01-08-2013

US generics drugmaker Mylan (Nasdaq: MYL) announced its financial results for the second quarter of 2013,…

FinancialGenericsMylan Laboratories

US Appeals Court overturns Copaxone patent decision

28-07-2013

Israel-based generics giant Teva Pharmaceutical Industries ((NYSE: TEVA) said on Friday (July 26) that…

CopaxoneGenericsLegalMomenta PharmaceuticalsMylan LaboratoriesNatco PharmaNeurologicalNorth AmericaNovartisPatentsPharmaceuticalSandozTeva Pharmaceutical Industries

Mylan strikes deal for Parkinson's disease drug Stalevo

26-07-2013

US generics firm Mylan (Nasdaq: MYL) and Finland-based drugmaker Orion Corp (Nasdaq OMX Helsinki: ORNAV)…

GenericsLicensingMylan LaboratoriesNeurologicalNorth AmericaOrion CorpPharmaceuticalStalevo

Mylan enters Tarceva settlement agreement

24-07-2013

US generics firm Mylan (Nasdaq: MYL) has entered into a settlement agreement with OSI Pharmaceuticals,…

GenentechGenericsLegalMylan LaboratoriesNorth AmericaOncologyOSI PharmaceuticalsPatentsPfizerTarceva

US appeals court reverses paroxetine order in favor of Mylan

23-07-2013

US generic drugmaker Mylan (Nasdaq: MYL) today (July 23) announced that the US Third Circuit Court of…

ApotexGenericsGlaxoSmithKlineLegalMylan LaboratoriesNeurologicalNorth AmericaparoxetinePatentsPaxil

1 to 25 of 94 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top